{"generic":"Fluorescein Sodium","drugs":["AK-Fluor","Angioscein","Fluor-I-Strip","Fluor-I-Strip A.T.","Fluorescein Sodium","Fluorescite","Fluorets","Ful-Glo","Ocu-Flur 10"],"mono":{"0":{"id":"236090-s-0","title":"Generic Names","mono":"Fluorescein Sodium"},"1":{"id":"236090-s-1","title":"Dosing and Indications","sub":[{"id":"236090-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Applanation tonometry:<\/b> place strip, which has been moistened with a drop of sterile water, at the fornix in the lower cul-de-sac close to the punctum; patient should close lid tightly over strip until desired amount of staining is observed OR retract upper lid and touch tip of strip to the bulbar conjunctiva on the temporal side until adequate staining is achieved<\/li><li><b>Ophthalmic fluorescence imaging:<\/b> 10% solution: 500 mg (5 mL) IV injected rapidly (1 mL per second) into the antecubital vein<\/li><li><b>Ophthalmic fluorescence imaging:<\/b> 25% solution: 500 mg (2 mL) IV injected rapidly into the antecubital vein<\/li><\/ul>"},{"id":"236090-s-1-5","title":"Pediatric Dosing","mono":"<ul><li>Safety and effectiveness not established in children<\/li><li><b>Ophthalmic fluorescence imaging:<\/b> 10% solution: 3.5 mg per pounds (7.7 mg\/kg) of body weight injected rapidly (1 mL per second) into the antecubital vein<\/li><\/ul>"},{"id":"236090-s-1-6","title":"Dose Adjustments","mono":"<b>use of highly sensitive imaging equipment (eg, scanning laser ophthalmoscope):<\/b> reduce fluorescein sodium 10% solution dose from 5 milliliters (500 milligrams) to 2 milliliters (200 milligrams) "},{"id":"236090-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Applanation tonometry<\/li><li>Ophthalmic fluorescence imaging<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><ul><li>Blocked lacrimal canaliculus; Diagnosis<\/li><li>Cerebrospinal fluid rhinorrhea; Diagnosis<\/li><li>Extraction of cataract<\/li><li>Scanning or imaging with vascular flow<\/li><li>Torsion of the ovary, ovarian pedicle or fallopian tube<\/li><\/ul>"}]},"3":{"id":"236090-s-3","title":"Contraindications\/Warnings","sub":[{"id":"236090-s-3-9","title":"Contraindications","mono":"<ul><li>concomitant soft contact lens use (ophthalmic strips)<\/li><li>hypersensitivity to any component of fluorescein<\/li><\/ul>"},{"id":"236090-s-3-10","title":"Precautions","mono":"<ul><li>bronchial asthma (injection)<\/li><li>history of allergy (injection)<\/li><\/ul>"},{"id":"236090-s-3-11","title":"Pregnancy Category","mono":"Fluorescein: C (FDA)<br\/>"},{"id":"236090-s-3-12","title":"Breast Feeding","mono":"<ul><li>Fluorescein: AAP: Maternal medication usually compatible with breastfeeding.<\/li><li>Fluorescein: WHO: Avoid breastfeeding.<\/li><li>Fluorescein: Micromedex: Infant risk cannot be ruled out.<\/li><\/ul>"}]},"5":{"id":"236090-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><ul><li><b>Dermatologic:<\/b>Discoloration of skin<\/li><li><b>Gastrointestinal:<\/b>Gastrointestinal irritation, Nausea (up to 20%.), Vomiting (up to 7%)<\/li><li><b>Renal:<\/b>Discolored urine<\/li><\/ul><b>Serious<\/b><ul><li><b>Cardiovascular:<\/b>Cardiac arrest, Myocardial infarction, Shock (Severe)<\/li><li><b>Dermatologic:<\/b>Injection site extravasation (up to 3%)<\/li><li><b>Immunologic:<\/b>Anaphylaxis<\/li><li><b>Neurologic:<\/b>Seizure<\/li><\/ul>"},"6":{"id":"236090-s-6","title":"Drug Name Info","sub":{"0":{"id":"236090-s-6-17","title":"US Trade Names","mono":"<ul><li>AK-Fluor<\/li><li>Angioscein<\/li><li>Fluor-I-Strip<\/li><li>Fluor-I-Strip A.T.<\/li><li>Fluorescite<\/li><li>Fluorets<\/li><li>Ful-Glo<\/li><li>Ocu-Flur 10<\/li><\/ul>"},"2":{"id":"236090-s-6-19","title":"Class","mono":"Disclosing Agent<br\/>"},"3":{"id":"236090-s-6-20","title":"Regulatory Status","mono":"RX<br\/>"},"4":{"id":"236090-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"9":{"id":"236090-s-9","title":"Administration","mono":"<b>Intravenous<\/b><br\/><ul><li>do not mix or dilute with other solutions drugs<\/li><li>flush IV cannulas before and after drugs are administered to avoid physical incompatibility.<\/li><li>avoid extravasation during injection (intense pain at site, ache in injected arm)<\/li><li>inject rapidly into antecubital vein (1 ml\/second)<\/li><li>luminescence appears in the retina or choroidal vessels in 7 to 14 seconds<\/li><li>dye should appear in central retinal artery in 9 to 15 seconds<\/li><\/ul>"},"10":{"id":"236090-s-10","title":"Monitoring","mono":"<ul><li>ophthalmic exam<\/li><li>(intravenous) vital signs, ECG; in patients with cardiac disease<\/li><\/ul>"},"11":{"id":"236090-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/>Intravenous Solution: 10 %, 25 %<br\/><\/li><li><b>AK-Fluor<\/b><br\/>Intravenous Solution: 10 %, 25 %<br\/><\/li><li><b>Angioscein<\/b><br\/>Intravenous Solution: 10 %, 25 %<br\/><\/li><li><b>Bio Glo<\/b><br\/>Ophthalmic Test: 1 MG<br\/><\/li><li><b>Fluorescite<\/b><br\/>Intravenous Solution: 10 %<br\/><\/li><li><b>Fluorets<\/b><br\/>Ophthalmic Test: 1 MG<br\/><\/li><li><b>Fluor-I-Strip A.T.<\/b><br\/>Ophthalmic Test: 1 MG<br\/><\/li><li><b>Ful-Glo<\/b><br\/>Ophthalmic Test: 0.6 MG, 1 MG<br\/><\/li><\/ul>"},"13":{"id":"236090-s-13","title":"Clinical Teaching","mono":"<ul><li>Warn patient after fluorescein injection that the skin may have a yellowish discoloration for about 6 to 12 h. Urine may also be discolored bright yellow for up to 36 h.<\/li><li>The injectable formulation may cause nausea, altered taste, vomiting, syncope, hypotension, or headache.<\/li><li>Instruct patient to remove soft contact lenses prior to testing with the ophthalmic preparation. Lenses should not be reinserted until 1 h after the test.<\/li><\/ul>"}}}